131 related articles for article (PubMed ID: 37699074)
21. Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective.
Dewilde S; Carroll K; Nivelle E; Sawyer J
Cost Eff Resour Alloc; 2020; 18():7. PubMed ID: 32063753
[TBL] [Abstract][Full Text] [Related]
22. Haematologic toxicities with PARP inhibitors in cancer patients: an up-to-date meta-analysis of 29 randomized controlled trials.
Wang C; Li J
J Clin Pharm Ther; 2021 Jun; 46(3):571-584. PubMed ID: 33421183
[TBL] [Abstract][Full Text] [Related]
23. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib.
Kristensen LE; Strober B; Poddubnyy D; Leung YY; Jo H; Kwok K; Vranic I; Fleishaker DL; Fallon L; Yndestad A; Gladman DD
Ther Adv Musculoskelet Dis; 2023; 15():1759720X221149965. PubMed ID: 36777695
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey.
Steurer M; Wagner H; Gastl G
Wien Klin Wochenschr; 2004 Jun; 116(11-12):367-72. PubMed ID: 15291288
[TBL] [Abstract][Full Text] [Related]
25. Mucormycosis-associated fungal infections in patients with haematologic malignancies.
Kara IO; Tasova Y; Uguz A; Sahin B
Int J Clin Pract; 2009 Jan; 63(1):134-9. PubMed ID: 17362481
[TBL] [Abstract][Full Text] [Related]
26. Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level.
Oh J; Kang CI; Kim SH; Huh K; Cho SY; Chung DR; Lee SY; Jung CW; Peck KR
Mycoses; 2020 Jan; 63(1):89-94. PubMed ID: 31610064
[TBL] [Abstract][Full Text] [Related]
27. The impact of outpatient chemotherapy-related adverse events on the quality of life of breast cancer patients.
Tachi T; Teramachi H; Tanaka K; Asano S; Osawa T; Kawashima A; Yasuda M; Mizui T; Nakada T; Noguchi Y; Tsuchiya T; Goto C
PLoS One; 2015; 10(4):e0124169. PubMed ID: 25915539
[TBL] [Abstract][Full Text] [Related]
28. Timing of referral to outpatient palliative care for patients with haematologic malignancies.
Patel S; Hoge G; Fellman B; Kaur S; Heung Y; Bruera E; Hui D
Br J Haematol; 2022 Sep; 198(6):974-982. PubMed ID: 35866185
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy.
Wang TF; Baumann Kreuziger L; Leader A; Spectre G; Lim MY; Gahagan A; Gangaraju R; Sanfilippo KM; Mallick R; Zwicker JI; Carrier M
J Thromb Haemost; 2021 Aug; 19(8):2068-2081. PubMed ID: 34327825
[TBL] [Abstract][Full Text] [Related]
30. Association Between Use of Anticancer Drugs and Cardiovascular Disease-Related Hospitalization in Metastatic Colorectal Cancer: Insights From a Population-Based Study, the Anticancer Vigilance of Cardiac Events Study.
Dolladille C; Launoy G; Bouvier V; Salem JE; Legallois D; Milliez P; Sassier M; Lobbedez T; Guittet L; Alexandre J
Am J Epidemiol; 2021 Feb; 190(3):376-385. PubMed ID: 32964219
[TBL] [Abstract][Full Text] [Related]
31. Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies:
Parashar S; Akhter N; Paplomata E; Elgendy IY; Upadhyaya D; Scherrer-Crosbie M; Okwuosa TM; Sanghani RM; Chalas E; Lindley KJ; Dent S
JACC CardioOncol; 2023 Apr; 5(2):159-173. PubMed ID: 37144116
[TBL] [Abstract][Full Text] [Related]
32. Risk of cardiovascular disease in breast cancer patients receiving aromatase inhibitors vs. tamoxifen: A systematic review and meta-analysis.
Yu Q; Xu Y; Yu E; Zheng Z
J Clin Pharm Ther; 2022 May; 47(5):575-587. PubMed ID: 34984740
[TBL] [Abstract][Full Text] [Related]
33. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.
Alexandre J; Salem JE; Moslehi J; Sassier M; Ropert C; Cautela J; Thuny F; Ederhy S; Cohen A; Damaj G; Vilque JP; Plane AF; Legallois D; Champ-Rigot L; Milliez P; Funck-Brentano C; Dolladille C
Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):312-320. PubMed ID: 32353110
[TBL] [Abstract][Full Text] [Related]
34. Physiological alterations involved in inactivation of autochthonous spoilage bacteria in orange juice caused by Citrus essential oils and mild heat.
de Souza Pedrosa GT; de Souza EL; de Melo ANF; da Cruz Almeida ET; de Sousa Guedes JP; de Carvalho RJ; Pagán R; Magnani M
Int J Food Microbiol; 2020 Dec; 334():108837. PubMed ID: 32890943
[TBL] [Abstract][Full Text] [Related]
35. The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies.
Gaiger A; Lubowitzki S; Krammer K; Zeilinger EL; Acel A; Cenic O; Schrott A; Unseld M; Rassoulian AP; Skrabs C; Valent P; Gisslinger H; Marosi C; Preusser M; Prager G; Kornek G; Pirker R; Steger GG; Bartsch R; Raderer M; Simonitsch-Klupp I; Thalhammer R; Zielinski C; Jäger U
Cancer Med; 2022 Sep; 11(18):3387-3396. PubMed ID: 35315594
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 vaccination in patients with cancer, a rapid review.
Chehade L; Zeitoun J; Lombe D; Irshad S; Hemelrijck MV; Canfell K; Sullivan R; Mukherji D
Ecancermedicalscience; 2022; 16():1355. PubMed ID: 35510135
[TBL] [Abstract][Full Text] [Related]
37. Topical Cyperus rotundus essential oil for treatment of axillary hyperpigmentation: a randomized, double-blind, active- and placebo-controlled study.
Mohammed GF
Clin Exp Dermatol; 2022 Mar; 47(3):534-541. PubMed ID: 34618367
[TBL] [Abstract][Full Text] [Related]
38. Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II.
Kim SB; Sayeed A; Villalon AH; Shen ZZ; Yau TK; Shah MA; Hou MF; Thuan TV; Ba DN; Chao TY
Asian Pac J Cancer Prev; 2016; 17(2):697-702. PubMed ID: 26925666
[TBL] [Abstract][Full Text] [Related]
39. Management of haematologic malignancies in pregnancy.
Wong GC
Ann Acad Med Singap; 2002 May; 31(3):303-10. PubMed ID: 12061290
[TBL] [Abstract][Full Text] [Related]
40. Emerging new anticancer biological therapies in 2013 (haematological malignancies).
Plawny L; Ries F
Curr Opin Oncol; 2014 May; 26(3):363-70. PubMed ID: 24663027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
